Grippostad C capsules

Country: Armenia

Language: English

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Active ingredient:

paracetamol, ascorbic acid, caffeine, chlorphenamine (chlorphenamine maleate)

Available from:

STADA Arzneimittel AG

ATC code:

N02BA71

INN (International Name):

paracetamol, ascorbic acid, caffeine, chlorphenamine (chlorphenamine maleate)

Dosage:

200mg+ 150mg+ 25mg+ 2,5mg

Pharmaceutical form:

capsules

Units in package:

(10/1x10/) in blister

Prescription type:

OTC

Authorization status:

Registered

Authorization date:

2017-09-05

Summary of Product characteristics

1
Summary of Product Characteristics
1. NAME OF THE MEDICINAL PRODUCT
Grippostad
®
C capsules, hard
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
1 capsule, hard contains 200 mg paracetamol, 150 mg ascorbic acid, 25
mg caffeine, 2.5
mg chlorphenamine hydrogen maleate.
For the full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
Capsule, hard
Capsule top: yellow opaque
Capsule bottom: white opaque, filled with white to yellowish powder.
4. CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Symptomatic treatment of common cold-related concurrently occurring
symptoms such as
headache and pain in limbs, rhinitis and dry cough.Grippostad
®
C reducesconcomitantly
occurring fever or increased body temperature.
Because of the fixed combination, doses of the single substances of
Grippostad
®
C cannot
be adjusted individually in cases where one of the mentioned symptoms
occurs predomi-
nantly. In these cases medicinal products with different compositions
should be preferred.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Adults and adolescents aged 12 years and overtake 2 capsules three
times a day.
Patients with hepatic and/or renal impairment
Dose must be reduced or dosing interval must be prolonged in patients
with impaired he-
patic or renal function and Gilbert's syndrome.
Grippostad
®
C must not be used with severe liver and/or kidney insufficiency (see
section
4.3).
METHOD AND DURATION OF ADMINISTRATION
The capsules are swallowed with a sufficient amount of fluid.
Grippostad
®
C should not be used over long periods of time or at high dosages
without
2
consulting a doctor.
4.3 CONTRAINDICATIONS

Hypersensitivity to the active substances or to any of the excipients
listed in section 6.1

Severely impaired kidney function

Children under 12 years of age

Pregnancy

Breast-feeding
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Grippostad
®
C should only be used with special caution or after consulting a
doctor with

Impaired renal function

Impaired hepatic function

Gilbert's syndrome
